Moreover, ATC exhibits a poor response to conventional treatments like surgery, radiotherapy, and chemotherapy, and shows limited efficacy with emerging therapies, including targeted therapies and immunotherapy [2]
Furthermore, the escalation of DULA given in a weekly dose of 3 mg or 4.5 mg has achieved further incremental reductions of body weight, regardless of baseline A 1c or BMI, compared with once-weekly 1.5 mg in patients with T2D [66]
By protecting neurons, reducing oxidative damage, and supporting overall brain energy metabolism, ALA and R-ALA contribute to improved cognitive function, sharper memory, and better mental clarity, making them valuable ingredients in nootropic and brain health supplements
157 MMT exhibits minimal systemic absorption due to its inability to permeate the GI epithelium, ensuring its elimination alongside adsorbed toxins without interfering with normal bowel function